By Will Feuer ArriVent BioPharma, a clinical-stage biopharmaceutical company, filed for an initial public offering. The company plans to list its stock on.
By Will Feuer ArriVent BioPharma named Winston Kung, the former chief operating officer and chief financial officer of PMV Pharmaceuticals, its next CFO.